Bristol-Myers Squibb is investing approximately $250 million to expand its large-scale biologics manufacturing facility in Devens, MA. The expansion will add biologics development and clinical trial manufacturing capabilities, and an additional 350 employees over time. Work on the expansion is expected to be completed in 2015.   Two new buildings on the 89-acre Devens campus will be dedicated to process development for early production of investigational biologics and clinical manufacturing to s...